Clinical trial
A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of Mecamylamine 5.0 to 10 mg, in the Treatment of Major Depressive Disorder With Subjects Who Are Partial or Non- Responders to Citalopram Therapy.
NCT00593879 is registered in ClinicalTrials.gov with Targacept Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of Mecamylamine 5.0 to 10 mg, in the Treatment of Major Depressive Disorder With Subjects Who Are Partial or Non- Responders to Citalopram Therapy.
- Lead sponsor
- Targacept Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- August 31, 2006
- Enrollment
- 450 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.